01.11.2012 Views

DRIVIN G ROWTH - Dr. Reddy's

DRIVIN G ROWTH - Dr. Reddy's

DRIVIN G ROWTH - Dr. Reddy's

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

42<br />

directors’ report<br />

1<br />

| Electricity<br />

Purchased<br />

2<br />

|<br />

Coal<br />

Annexure to the directors’ report<br />

FORM A<br />

Form for Disclosure of Particulars with<br />

respect to Conservation of Energy.<br />

A. Power and fuel consumption<br />

CURRENT YEAR (2001-02) PREVIOUS YEAR (2000-01)<br />

Unit 49,099,022 43,564,664<br />

Total amount Rs. 202,287,970 Rs. 187,066,404<br />

Rate/unit Rs. 4.12 Rs. 4.29<br />

Own generation – through diesel generator set<br />

Unit 4,482,455 6,046,313<br />

Units per ltr. of diesel oil 3.32 3.38<br />

Cost/unit 5.11 Rs. 4.11<br />

(Used in boiler)<br />

CURRENT YEAR (2001-02) PREVIOUS YEAR (2000-01)<br />

Quantity (tonnes) 18,565 18,119<br />

Total Cost (Rs.) 41,350,970 28,363,241<br />

Average rate 2,227 1,565<br />

FORM B<br />

Research and Development (R & D)<br />

1.Specific areas in which R & D carried<br />

out by the Company.<br />

• Development of commercially viable<br />

processes for pharmaceutical products and<br />

new polymorphism with a good market<br />

potential worldwide<br />

• Development of alternate routes of<br />

DR. REDDY’S LABORATORIES LTD. | DIRECTORS’ REPORT | ANNUAL REPORT 2001-2002<br />

synthesis for products already<br />

commercialised. Study of impurity<br />

profiles of products<br />

• Development of non-infringing process,<br />

to become a API source for Generic<br />

customers<br />

• Product development of generic products<br />

for ANDA/Dossier submission and<br />

approval. Patent non-infringing<br />

technologies and patentable technologies<br />

for the regulated markets like USA,<br />

Europe<br />

• Novel <strong>Dr</strong>ug Delivery Systems<br />

• Analytical Research & Development<br />

including impurity identification,<br />

polymorph identification<br />

• Bio analytical research and development<br />

for the development of bio-equivalent<br />

products<br />

• Development of products for human care<br />

• Analytical methods development,<br />

• Quality improvements,<br />

• Alternate vendors development for<br />

existing materials,<br />

• Cost reduction and<br />

• Packaging development for new products,<br />

improvements in existing packs

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!